|
Adult Trials: Breast Cancer
|
|
Protocol#
|
Principal Investigator
|
Title
|
UCI 07-61 |
Mehta |
A Pase II Study of Breast Cancer Treatment using weekly Carboplatin + Nabpaclitaxel, plus Trastuzmad (HER2+) and Bevacizumab (HER2-) in the Neoadjuvant setting |
IBCSG 25-02 |
Mehta |
A Phase III Trial Evaluating the role of Exemestane + GnRH Analogue as Adjuvant Therapy for Premenopausal women with Endocrine Response Breast cancer
(ON HOLD)
|
| UCI 03-16 |
Mehta |
Phase II Chemoprevention Trial – Anastrozole in the DCIS and Early Invasive Breast Cancer in Postmenopausal Women |
| SWOG S0226 |
Mehta |
Phase III Randomized Trial of Anastrozole versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women with Metastatic Breast Cancer |
NSABP B-42 |
Mehta |
A Clinical Trial to Determine the Efficacy of 5 years of Letrozole Compared to Placebo in Pts Completing 5 years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer |
| NSABP B36 |
Mehta |
A Clinical Trial of Adjuvant Therapy Comparing Six Cycles of 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) to Four Cycles of Adriamycin and Cyclophosphamide (AC) in Patients With Node-Negative Breast Cancer |
| UCI 00-09 |
Nalcioglu |
Angiogenesis in Early Breast Cancer For Prognosis Prediction |
| UCI 99-49 |
Gottschalk |
The Effects of Anticancer Chemotherapeutic Drugs on Cognitive Function and Other Neuropsychiatric Functions
|
| UCI 99-44 |
Nalcioglu |
Analysis of Breast MRI for Functional Onco-Imaging |
| UCI 95-29 |
Tromberg |
Measurement of Breast Optical Properties |
| UCI 04-57 |
Lee |
Expression of NPGPX Novel Glutathione Peroxidase in Human Breast Cancer Specimen |
| UCI 03-63 |
Samoszuk |
Fibroblasts, Inflammation, and Breast Cancer |
| UCI 03-35 |
Samoszuk |
MT1-MMP Pericellular Proteolysis in Malignancy (A.K.A. MT1-MMP Regulates the Wnt Signaling and Invasiveness of Breast Cancer) |
| UCI 02-68 |
Blumberg |
(1) SXR: A Target for Breast Cancer Prevention & Treatment
(2) Species Specific Xenobiotic Metabolism Mediated by the Steroid and Xenobiotic Receptor |
| UCI 02-10 |
Hsiang |
Monitoring the Response of Chemotherapy on Breast Cancer Tumors by Photon Migration Spectroscopy
|
For additional information on open UCI clinical trials please call toll-free 1-877-UC-STUDY or email ucstudy@uci.edu.